Human urine is known to contain substances that strongly inhibit bacterial mutagenicity of aromatic and heterocyclic amines in vitro. The biological relevance of these antimutagens was examined by comparing levels of tobaccorelated DNA adducts in exfoliated urothelial cells from smokers with the anti-mutagenic activity in corresponding 24-h urine samples. An inverse relationship was found between the inhibition of 2-amino-l-methyl-6-phenylimidazo 
Introduction
Tobacco smoking causes a major fraction of urinary bladder cancer in humans (1). Previous studies have implicated primary aromatic and possibly heterocyclic amines as bladder carcinogens which are present in tobacco smoke (2) . We have shown human urine from both smokers and non-smokers to contain substances that strongly inhibit the bacterial mutagenicity of aromatic and heterocyclic amines in vitro (3) . The current report presents data on the characterization of the chemical nature and mode of action of these urinary anti-mutagens. The biological relevance was assessed by examining the relationship between the levels of tobacco-related DNA adducts in exfoliated urothelial cells and the anti-mutagenic activity in the 24-h urine of smoking volunteers. Based on the results, the role of various naturally occurring anti-mutagens in human diet is discussed.
Materials and methods

Materials
Bond Elut C-18 cartridges used to prepare urinary extracts were produced by Varian, Harbor City, CA. Phenolics were purchased from Extrasynthese, Lyon, France. [3-glucuronidase (from E. coli type IX) were purchased from Sigma Chemical Company, St Louis, MO. Arylsulfatase (from Helix pomatia) was purchased from Boehnnger-Mannheim, Germany. All other solvents and reagents were of analytical purity.
Preparation of urine extracts
Twenty-four-hour urine samples from healthy male blood donors were collected in polyethylene bottles which were stored at 4°C during the collection period. Part of each sample was used to prepare exfoliated cells as previously described (4) . The remaining urine samples were stored for up to 4 years at -30°C. Samples of working-day urine from healthy male and female volunteers from IARC laboratories were also collected and stored, as described above, and analysed within 1-3 weeks. Nicotine, cotinine and creatinine in urine samples were determined as described (5) . The urine extracts were prepared using Bond Elut cartridges containing 500 mg C-18 sorbent according to a procedure established in our laboratory. Extractions were performed as follows: cartridges were first rinsed with 24 ml of a methanol/water mixture (50/50) and 40 ml of deionized water, then aliquots of urine samples containing 3 mg creatinine were applied, after adjustment, to 4 ml with deionized water. Cartridges were washed with 20 ml deionized water. Organic materials Relationship between the anti-mutagenic activity of urine extracts (using PhIP as mutagen) and their content in phenolic substances (r = 0.58, P < 0.02; n = 18). The anti-mutagenic activities were calculated as described in the legend to Figure I . The mutagenicity of 20 ng PhIP after 45 min liquid incubation in the absence of inhibitor ranged from 665 to 1100 revertants per plate for 15 series of experiments each involving two or three duplicate determinations, the mean value ± SE was 800 ± 30.
adsorbed on the resin were eluted with 12 ml methanol. Methanol/water, water, urine and methanol were pumped through the cartridges at a flow rate of 4-5 ml/min. Methanolic eluates were reduced to dryness by vacuum evaporation at room temperature. The residues were taken up in 50 |il of DMSO and stored at -70°C for up to 2 weeks. Some extracts were also prepared according to a procedure described previously by passing 220 ml of urine aliquots through a column of XAD-2 resin and elution with dichloromethane followed by acetone (5) . After evaporation of the solvent, the residues were dissolved in 500 |il of DMSO and stored at -70°C for not more than 1 month.
DNA isolation and measurement of tobacco-related carcinogen-DNA adducts
DNA was extracted from exfoliated urothelial cells, hydrolysed, [
32 P]postlabelled and carcinogen-DNA adduct levels measured as described (4) .
Salmonella mutagenicity assay
Salmonella typhimunum TA98 strain was supplied by B.N. Ames (Berkeley, CA). Using a modified liquid incubation assay described by Malaveille et al. Assay for cytotoxic activity in Escherichia coll PQ 37 Escherichia coli PQ 37 strain was supplied by P.Quillardet (Pans, France). The SOS chromotest (6) was earned out with a metabolic activation system identical to that used for the Salmonella liquid incubation assay. Enzyme activity (indicating surviving fraction) was measured as desenbed, after incubation with a DMSO solution of the urine extract or the phenolics and PhIP in concentrations identical to those used in the Salmonella assays (5).
Enzymatic dcconjugalion of urinary glucuronides and sulfates
An aliquot of 24-h urine containing 3 mg creatinine (1.9-3.3 ml depending on the sample) was mixed with 1 ml 0.5 M Sorensen citrate buffer, pH 6, with or without up to 40 000 Roy units of arylsulfatase and 5000 Fishman units of p-glucuronidase. The final volume was adjusted to 6 ml with deionized water. The mixture was flushed for 30 s with nitrogen, incubated for 1 h at 37°C and extracted using a Bond Elut C-18 cartridge as described above for urine; the residue was taken up in 50 |il DMSO and stored at -70°C for not more than 1 week.
Spectrophotometric analysis of phenolics in urinary and food/beverage extracts
The amount of phenolics in DMSO solutions of extract or concentrate of urine, wine, HPLC fractions and aqueous food extracts, was measured by analysing the total phenol concentration by the Folin-Ciocalteu procedure of Singleton and Rossi (7) using gallic acid for the calibration curve. Briefly, 10 nl of DMSO solution of extract/concentrate or gallic acid were mixed with 190 |il deionized water, 1 ml of a 10-fold diluted aqueous Folin-Ciocalteu Dietary phenolics reagent and 0.8 ml 7.5% (w/v) anhydrous Na 2 CO3 in aqueous solution. The absorbance at 750 nm was measured after 1 h incubation at room temperature.
Preparation of extracts of aqueous food extracts or wine
Fifty grams of apple were homogenized at room temperature with 20 ml, 50 g of lettuce with 40 ml and 50 g of onion with 50 ml deionized water using a Waring blender. The homogenates were centrifuged for 10 min at 2000 g; 5 ml of each supernatant were applied to a Bond Elut C-18 cartridge as described for the preparation of urine extract. In the case of wine, 5 ml of 10-or 50-fold diluted aqueous solution were applied. The dry extracts of diluted wine, aqueous extract of apple and lettuce were dissolved in up to 100 |il DMSO for the analysis of phenolics and anti-mutagenicity or in acetonitrile/H 2 O (50/ 50) for fractionation by HPLC.
HPLC separation of unne and food extracts
The residues from Bond-Elut C-18 cartridge extractions (see above) were dissolved in 100 Jll acetonitrile/H 2 O (50/50) and separated by HPLC on a C-18 LC column (Supercosil, 3 u.m; L: 15 cm; ID: 4.6 mm). Solvent A was 10% acetic acid in H 2 O; solvent B was acetonitrile. The solvents were programmed from an initial concentration of 0-100% B at 60 min and held isocratically until 72 min. The following gradient was applied: 0-12 min 7% B; 12-50 min from 7-30% B; 50-60 nun from 30-100% B. Flow rate was 0.5 rruVmin. The separation was monitored by UV absorption at 254 mm. After injection, six fractions (6 ml each) were collected. They were reduced to dryness by vacuum evaporation at room temperature and redissolved in 50 nl DMSO for analysis of anti-mutagenicity and phenolics.
Results
To investigate whether urinary anti-mutagens can reduce DNA adduction in the urinary bladder of smokers, arising from exposure to aromatic (and possibly heterocyclic) amines, we compared urinary anti-mutagenicity measured in 24-h urine samples of 10 smoking volunteers with the level of DNA adducts in exfoliated cells isolated from the same urine. The mean relative adduct labelling (RAL) of DNA from these urothelial cell preparations and the association with tobacco smoking have been reported previously (4, 8) . DNA adducts were detected in 10 out of 18 samples from smokers (4). Three adducts were related to cigarette smoking, one being the putative .A/-(deoxyguanosine-8-yl)-4-aminobiphenyl (ABP-dG) adduct, and thus were considered for our investigations. The level of the putative ABP-dG-adduct and-the total of the three tobacco-related adducts were found to be linearly related to the number of cigarettes smoked per day. They were therefore expressed per the sum of nicotine plus cotinine contents in 24-h urine, to adjust for tobacco smoking. Both ABP-dG and total DNA adducts were found to be inversely related to bacterial anti-mutagenicity, expressed as the decrease in the number of revertants 6f S.typhimurium TA98 per ml urine equivalent. The latter was measured in liquid incubation assays, using PhIP as a representative mutagen for tobacco smokerelated heterocyclic amines. The logarithms of DNA adduct level versus anti-mutagenkity were linearly related, showing statistical significance (r = -0.81, P < 0.01 for both adduct measurements; Figure 1 ).
Since urinary excretion of plant phenolics, the human daily intake of which is up to 1 g (9,10), (i) has been reported (11,12) and (ii) some of them have been shown to inhibit the mutagenicity of various aromatic and heterocyclic amines (13-16) the amount of phenolics was measured in 19 human urine extracts using a spectrophotometric assay (7) . The concentrations were then compared to the urinary anti-mutagenicity, using PhIP as mutagen in S.typhimurium TA98. All the urine extracts contained phenolics, at concentrations of 3.7-12. of about 10. A statistically significant linear relationship was found between the anti-mutagenicity of urine extracts and their content in phenolic substances (r = 0.58, P < 0.02, n = 18; Figure 2 ). One sample (not shown) exhibited anti-mutagenic activity about six times greater than that predicted from its content in phenolics. In order to examine further the role of plant phenolics as urinary anti-mutagens, we assayed a series of representative flavonoids and other plant phenols to determine whether their inhibitory concentrations match those of the phenolics in urinary extracts. The chemical class, name and structure of representative naturally occurring phenolics are given in Table  I . Inhibitory effects of various plant phenols on the liver S9-mediated mutagenicity in S.typhimurium TA98 of two heterocyclic amines, MelQx and PhIP are presented in Table II . The absence of bacterial toxicity by phenolics, which might interfere with their anti-mutagenicity, was verified by using SOS chromqtest. This sensitive test for cytotoxicity, carried out under experimental conditions identical to those used for the Salmonella assay, showed that at the concentration range used the phenolics did not decrease bacterial survival, (expressed as alkaline phosphatase activity, see Materials and methods; data not shown). At concentrations ranging from 0.2 to 6 (ig per assay, the highest inhibitory effects were obtained with flavonols, flavones, flavanones and one anthocyanidin. All the other substances tested (two isoflavones, two phenolic acids and one flavanol) had no inhibitory activity or very little. Within a particular class of inhibitory substances, the glycosides (i.e. O-rhamnoglucoside) were relatively inactive compared with their aglycone moiety, as shown for quercetin versus quercitrin and naringenin versus naringin (Table II) . The presence of a methyl group on the catechol moiety of a flavonoid did not alter the anti-mutagenic activity (luteolin versus diosmetin), but led to an increase of about 6-fold in the case of quercetin versus isorhamnetin. Dietary phenolics are partly excreted in urine as glucuronides and sulfates (11,12). Two urine samples were therefore treated with fj-glucuronidase and arylsulfatase before the preparation of extracts. The effect of deconjugation on the anti-mutagenic activity of urine extracts and the liberation of free phenolics is shown in Figure 3A -C. After enzymatic treatment, antimutagenicity increased maximally 11-fold (based on the linear part of the dose-response curves Figure 3A, B) and the level of phenolics 2.5-fold. Based on combined results from two extracts, the increase in anti-mutagenicity was linearly related to the concentration of unconjugated phenolics ( Figure 3C ). These data strongly suggest that these free phenolic substances act as inhibitors of liver S9-mediated mutagenicity of PhIP.
To gain further evidence for the role of phenolics as urinary anti-mutagens, the mode of inhibition of liver S9-mediated mutagenicity of PhIP was determined for three urinary extracts and compared with that of quercetin. As inferred from double reciprocal plots (Figure 4) , both the extracts and the pure flavonoid, quercetin, inhibited the mutagenicity of PhIP in a non-competitive fashion.
In order to identify the origin of anti-mutagenic substances in urinary extracts, chromatographic separations were performed using conditions reported to be efficient for separation of "20 ng PhIP were used in liquid incubation assays; the scored mutagenic effects in the absence of inhibitors ranged from 320-860 revertants per plate, for seven series of duplicate experiments, the mean value ± SE was 612 ± 70. Percentage inhibition was calculated from the pseudo-hnear part of inhibition curves; they are mean values of two duplicate measurements.
flavonoids (17, 18) . When two urinary extracts were subjected to reverse-phase HPLC, the UV absorption profiles revealed a complex elution pattern ( Figure 5A, B) . Subsequently, six fractions, covering the entire chromatographic profile, were analysed. All contained substances that inhibited liver S9 mutagenicity of PhIP, the most active fractions being 1 and 5. However, when the anti-mutagenicity of the fractions was expressed as a percentage inhibition per (ig phenolics, fraction 6 in both urine extracts exhibited the highest specific inhibitory activity.
Onion, lettuce, apple and red wine are important dietary sources of flavonoids (9) . Crude water extracts and wine (see Materials and methods) exhibited anti-mutagenic activity (Table HI) |xl (red wine) equivalent, wine was most active as anti-mutagen. However, when expressed per fig phenolics in the extract, the anti-mutagenic activity of onion extract was about 4-fold higher than that of wine (Table HI) . These complex extracts were also subjected to reverse-phase HPLC, as carried out for urinary extracts. The HPLC fraction 1 of wine extracts was found to contain most of the activity. In the onion extract, most of the UV-absorbing material and anti-mutagenic substances appeared in fractions 3-6; when expressed as percentage inhibition per \ig phenolics, fraction 6 contained agents with the highest specific inhibitory activity ( Figure 6A, B) .
Discussion
The present work was conducted as a part of a series of molecular dosimetry and biochemical epidemiological studies with the aim of elucidating the mechanisms involved in tobacco smoking-related bladder cancer [reviewed in (2) ]. The previous studies have reinforced the association between cigarette smoking and carcinogen-DNA adducts in exfoliated urothelial cells, and have implicated aromatic and possibly heterocyclic amines as bladder carcinogens. Extracts of 24-h human urines (stored at -30°C) that were collected for this multicentre investigation were shown to contain substances that strongly inhibited the liver S9-mediated mutagenicity of these urinary putative bladder carcinogens in bacteria. The inhibitory effect was not related to bacterial cytoxicity and was similar in urine extracts from smokers and non-smokers, suggesting a dietary origin. The biological relevance of these bacterial anti-mutagens was examined by comparing the levels of tobacco-related DNA adducts in exfoliated urothelial cells from smoking volunteers (4) with the anti-mutagenic activity in the corresponding 24-h urine samples. A strong inverse relationship was found between the inhibition by urine extracts of PhIP 2198 mutagenicity in vitro and the level of two DNA adduct measurements: one concerns the putatively identified ABP-dG adduct and the second, the total of tobacco-smoke-related carcinogen adducts, including those probably derived from PhIP. Urinary anti-mutagenicity in vitro thus appears to be a good indicator of the anti-genotoxicity exerted by substances excreted in urine that protect the bladder mucosal cells (and possibly other cells) against DNA damage due to substances derived from tobacco smoke. Since extracts were prepared from urines of subjects who were also coffee drinkers, we first suspected caffeine and paraxanthine (a demethylated caffeine metabolite) as inhibitors. Both are known to be substrates for cytochrome P450 IA2-mediated reactions, as are aromatic and heterocyclic amines (19, 20) . Caffeine has been reported to inhibit the mutagenicity of various heterocyclic amines in Salmonella (15, 21, 22) However, analysis of urine extracts by HPLC revealed that the concentrations of these methylxanthines in urinary extracts were far too low to account for their inhibitory effect on PhIP mutagenicity, as reported previously (3) . An inhibitory effect of unsaturated fatty acids on the mutagenicity of heterocyclic amines and other carcinogens has been reported (23) and their presence in human urine is well documented (24) . We therefore measured the concentration of the most abundant, linoleic and oleic acid, in urine extracts by gas chromatography [after methylation, as described by Hayatsu et al. (25) ]. The results (not shown) indicated again that the concentrations of these fatty acids were too low to account for the observed urinary anti-mutagenicity.
We then focused on phenolics because (i) human dietary intake of flavonoids is up to 1 g/day (9,10), (ii) they are partly excreted in urine (12, 26) , and (iii) some had been shown to inhibit the mutagenicity of aromatic and heterocyclic amines (13) (14) (15) . The following pieces of experimental evidence suggest that much of the urinary anti-mutagenicity is attributable to dietary phenolics and their metabolites: (i) the anti-mutagenic activity found in human urine extracts (n = 18) was linearly related to their content in phenolics; (ii) the level of these substances in urine extracts (Figure 2 ) is similar to the concentration ranges of various plant phenols (quercetin, isorhamnetin and naringenin) for which an inhibitory effect on liver S9-mediated mutagenicity of PhIP was demonstrated (Table II) ; (iii) treatment of urine with p-glucuronidase and arylsulfatase enhanced both anti-mutagenicity of urinary extracts and their contents in phenolics, with a linear relationship between these two variables ( Figure 3C) ; and (iv) three urinary extracts inhibited liver S9-mediated mutagenicity of PhIP in a non-competitive fashion, as did quercetin, used as a model compound ( Figure 5 ).
Our study has also revealed several structural features of the flavonoids that are required for inhibition of the bacterial mutagenicity of MelQx and PhIP (Table II) . Some of these have also been reported to be necessary for inhibition of liver microsome-mediated metabolism of benzo[a]pyrene (27) . Our results indicate that (a) the intact flavone ring system is required for optimal inhibitory activity (flavonols versus the d-catechin); (b) saturation of the 2,3 double bond in flavones leads to a decrease in activity (diosmetin versus hesperitidin); (c) the substituent at position C-4' (luteolin versus diosmetin) and a free OH-group at C-3 (flavonols versus flavones) are not critical for activity. Two isoflavones, genistein and daidzein, had no inhibitory activity. In contrast to our findings, genistein has been reported to be as active as flavones in inhibiting the metabolism of benzo[a]pyrene mediated by Aroclor-treated rat liver microsomes. This suggests that genistein does not inhibit P450 IA2-mediated activation of heterocyclic amines, while flavonoids inhibit P450 IA1, P450 3A4 and P450 IA2 that metabolize polycyclic aromatic hydrocarbons (19, 20, 28) . None of the phenolics tested (except quercetin at the highest concentration assayed) exhibited mutagenic activity at concentrations required for the inhibition of liver S9-mediated mutagenicity of PhIP and MelQx. The mutagenicity of flavonoids carrying a catechol moiety (e.g. quercetin) has been attributed to metabolic activation by redox cycling involving these catechols and their corresponding quinones (29) . These phenolics are rapidly 0-methylated by catechol-O-methyltransferase (COMT) in vitro and in vivo into non-mutagenic methoxy derivatives (30) . Interestingly, we found that isorhamnetin, the 3'-0-methyl derivative of quercetin, is a much stronger inhibitor of PhIP mutagenicity than quercetin itself (see Table II ), as reported previously for other heterocyclic amines (14) . This O-methylation has been proposed as a reason for the absence of toxicity of these compounds in vivo (30) . 0-Methylation renders them more lipophilic than the parent flavonoid, allowing a stronger interactions with cytochrome P450 within microsomal membranes. Published data on the mechanism(s) by which flavonoids inhibit rat liver monooxygenase indicating that a combination of electrostatic and lipophilic interactions are required for membranal transport processes and the binding of flavanones to cytochrome P450 are compatible with this notion (31) .
Analysis of two urinary extracts fractionated by reversephase HPLC indicates that all six fractions contained antimutagenic substances and phenolics ( Figure 5A, B) . Fraction 6, containing the most lipophilic substances, displayed the highest inhibitory activity when expressed per (ig phenolics. It is likely that in the human body, dietary flavonoids are enzymatically converted into O-methylcatechols, which are both more lipophilic and, thus, more anti-mutagenic than the parent compounds, as noted for quercetin. Onion, lettuce, apple and red wine are important dietary sources of flavonoids (9) and these substances are probably responsible for the antimutagenicity observed in their extracts (Table IH) . The distribution of anti-mutagenic activity in the HPLC fractions of urinary extracts corresponds roughly to a combination of inhibitors present in onion and wine extracts ( Figure 6A , B versus Figure  5A , B), suggesting that these phenolics and their metabolites comprise a major part of the complex mixture of urinary antimutagens.
Human diet contains a wide variety of non-nutrient agents, mostly phenolics of plant origin, which inhibit carcinogenesis in animals (32) (33) (34) (35) . Epidemiological observations have confirmed a protective effect of vegetable and fruits against the occurrence of many epithelial cancers (36) (37) (38) . Phenolics in the human diet could affect die pharmacokinetics of carcinogens by (i) altering the rates of their absorption and uptake, (ii) reacting with or tightly binding to toxic substances and metabolites, and (iii) modifying cytochrome P450-dependent metabolism and phase II enzymes (23, (33) (34) (35) 39) . The inverse relationship between urinary anti-mutagenicity and level of tobacco-related DNA adducts in the urothelium, reported here for the first time, strongly suggests that bladder mucosal cells of smokers are partially protected by dietary phenolics, most probably flavonoids, against the harmful effects of tobacco-derived bladder carcinogens. Studies are warranted to explore further these protective effects of phenolics from vegetables and fruits against cancers in humans as a part of a cancer chemoprevention strategy.
